Antitumor?agent-109

Antitumor?agent-109 Suppliers list
Company Name: Tianjin Kailiqi Biotechnology Co., Ltd.  
Tel: 15076683720
Email: klq@cw-bio.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: Jinan Jiuli Biotechnology Co. , Ltd.  
Tel: 15865264761
Email: 486064515@qq.com
Company Name: Shaoguan Qicheng Biotechnology Co., Ltd  
Tel: 18122215013
Email: 780229652@qq.com
Company Name: Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd  
Tel: 025-5885952 15955137747
Email: sales@aikonchem.com
Antitumor?agent-109 Basic information
Product Name:Antitumor?agent-109
Synonyms:Antitumor?agent-109;5-Bromo-2-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline
CAS:3052354-70-5
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Antitumor?agent-109 Structure
Antitumor?agent-109 Chemical Properties
form Solid
color White to off-white
Safety Information
MSDS Information
Antitumor?agent-109 Usage And Synthesis
UsesAntitumor agent-109 (compound 6) is an inhibitor of hyaluronic acid (HY-B0633A) targeting to CD44, as well as an anti-tumor agent. Hyaluronic acid interacts with differentiation cluster 44 (CD44) and is involved in tumor growth and invasion. Antitumor agent-109 inhibits MDA-MB-231 cells with EC50 value of 0.59 μM[1].
References[1] Espejo-Román JM, et al. N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect. Eur J Med Chem. 2023 Oct 5;258:115570. DOI:10.1016/j.ejmech.2023.115570
Antitumor?agent-109 Preparation Products And Raw materials
Tag:Antitumor?agent-109(3052354-70-5) Related Product Information
Vandortuzumab Vedotin VJDT Anti-cancer compound library Tinurilimab Polatuzumab vedotin Lirilumab